Operation and verification of a portable clinical analysis system

US9952194B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9952194-B2
Application numberUS-201314099419-A
CountryUS
Kind codeB2
Filing dateDec 6, 2013
Priority dateDec 17, 2012
Publication dateApr 24, 2018
Grant dateApr 24, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention covers the integration and utility of accelerometer features into a clinical analysis system. For example, measurement of dynamic acceleration and orientation of a blood-testing instrument with respect to Earth's gravitational field may be used to determine reliability of a test procedure and optionally to provide corrective elements thereof.

First claim

Opening claim text (preview).

We claim: 1. A portable clinical system for in vitro analysis, the system comprising: an analyzer configured to perform an in vitro analytical test on a sample obtained from a patient, the analyzer comprising: a port configured to receive a test device; and a computing device comprising at least one accelerometer and a processor, wherein the computing device is configured to: measure dynamic acceleration to determine motion of the analyzer; determine that the analyzer is in free fall based on the at least one accelerometer sensing the free fall as a predetermined value or was in free fall followed by a subsequent impact based on the at least one accelerometer sensing the free fall as the predetermined value and a sudden change in rate of acceleration after the free fall as the subsequent impact; lock the analyzer from performing the in vitro analytical test using the test device, when the analyzer is determined to be in the free fall or have been in the free fall followed by the subsequent impact; provide an alert prompting a user that a system performance verification is required to unlock the analyzer; provide a first time-stamp of when the analyzer is locked; perform the system performance verification on the analyzer; provide a second time-stamp of when the system performance verification is performed; store the first time-stamp and the second time-stamp such that there is a record of the analyzer being in free fall and that the system verification was performed; and, unlock the analyzer after the system performance verification is performed successfully. 2. The system of claim 1 , wherein the computing device stores the first time-stamp and the second time-stamp in an electronic auditable system. 3. The system of claim 2 , wherein the computing device is further configured to: determine whether the system performance verification fails; and communicate the failure of the system performance verification to the electronic auditable system. 4. The system of claim 3 , wherein the electronic auditable system is configured to perform replacement of the analyzer, and the processor is further configured to display a status of the replacement on the analyzer. 5. The system of claim 1 , wherein the computing device is further configured to communicate automatically and wirelessly an operational status of the analyzer to a remote entity based on the system performance verification. 6. The system of claim 1 , wherein: the analyzer further comprises a display; and the alert comprises at least one of: a visual alarm, an audible alarm, a notice on the display of the analyzer, and a message sent wirelessly to a predetermined entity. 7. The system of claim 6 , wherein the predetermined entity is at least one of a person responsible for integrity of the system, a distributor of the system, and a manufacturer of the system. 8. The system of claim 1 , further comprising the test device. 9. The system of claim 1 , wherein the predetermined value is about zero. 10. The system of claim 9 , wherein the analyzer further comprises: a display; a measurement module comprising actuators; and the computing device is further configured to (i) retract the actuators and/or (ii) turn off power to the display, when the computing device determines that the analyzer is in the free fall. 11. The system of claim 10 , wherein the dynamic acceleration is about zero for a predetermined amount of time. 12. The system of claim 1 , wherein the analyzer is configured to collect acceleration data intermittently or continuously throughout time, optionally including during a test cycle of the analyzer, and the computing device is configured to determine that the analyzer is in the free fall or was in the free fall followed by the subsequent impact based on the collected acceleration data. 13. A method comprising: initiating a test cycle of a test device using an analyzer to perform an in vitro analytical test on a sample obtained from a patient; determining, using acceleration data collected by an at least one accelerometer within the analyzer, that the analyzer is in free fall based on the at least one accelerometer sensing the free fall as a predetermined value or was in free fall followed by a subsequent impact based on the at least one accelerometer sensing the free fall as the predetermined value and a sudden change in rate of acceleration after the free fall as the subsequent impact; locking the analyzer from performing the in vitro analytical test, when the analyzer is determined to be in the free fall or has been in the free fall followed by the subsequent impact; providing an alert prompting a user that a system performance verification is required to unlock the analyzer; providing a first time-stamp of when the analyzer is locked; performing the system performance verification on the analyzer; providing a second time-stamp of when the system performance verification is performed; unlocking the analyzer if the system performance verification is performed successfully or communicating the failure of the system performance verification to an electronic auditable system if the system performance verification fails; and storing the first time-stamp and the second time-stamp such that there is a record of the analyzer being in free fall and that the system verification was performed, wherein the steps of determining through storing are performed and/or triggered by a computing device. 14. The method of claim 13 , further comprising: if the system performance verification fails, performing replacement of the analyzer using the electronic auditable system; and displaying a status of the replacement on the analyzer. 15. The method of claim 13 , wherein the analyzer collects the acceleration data intermittently or continuously throughout time, optionally including during the test cycle of the analyzer.

Assignees

Inventors

Classifications

  • Blood {(chemical methods for determining blood cell populations G01N33/5094; chemical analysis of blood groups or blood types G01N33/80)} · CPC title

  • Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771) · CPC title

  • Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply · CPC title

  • G01N33/48Primary

    Biological material, e.g. blood, urine (G01N33/02, G01N33/26, G01N33/44, G01N33/46 take precedence); Haemocytometers (counting blood corpuscules distributed over a surface by scanning the surface G06M11/02) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9952194B2 cover?
The present invention covers the integration and utility of accelerometer features into a clinical analysis system. For example, measurement of dynamic acceleration and orientation of a blood-testing instrument with respect to Earth's gravitational field may be used to determine reliability of a test procedure and optionally to provide corrective elements thereof.
Who is the assignee on this patent?
Abbott Point Of Care Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/48785. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).